Beta Drugs Ltd

Beta Drugs Ltd Half Yearly Results

NSEBSE

₹1,790.2

(-1.49%)

Apr 30, 2025|03:40:02 PM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Sept-2024	Mar-2024	Sept-2023	Mar-2023	Sept-2022
Gross Sales	180.3	154.45	141.27	114.72	112.39
Excise Duty	0	0	0	0	0
Net Sales	180.3	154.45	141.27	114.72	112.39
Other Operating Income	0	0	0	0	0
Other Income	1.51	0.82	0.54	0.43	0.33
Total Income	181.81	155.27	141.81	115.15	112.72
Total Expenditure	141.5	127.3	108.41	88.4	85.58
PBIDT	40.31	27.96	33.39	26.75	27.13
Interest	1.83	1.45	1.37	1.27	1.14
PBDT	38.49	26.51	32.02	25.47	25.99
Depreciation	5.71	4.34	5.44	5.58	4.83
Minority Interest Before NP	0	0	0	0	0
Tax	8.55	5.61	6.92	5.33	5.52
Deferred Tax	-0.21	0	-0.21	-0.32	-0.2
Reported Profit After Tax	24.44	16.56	19.87	14.88	15.83
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	24.44	16.56	19.87	14.88	15.83
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	24.44	16.56	19.87	14.88	15.83
EPS (Unit Curr.)	25.42	17.23	20.67	15.48	16.47
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	9.61	9.61	9.61	9.61	9.61
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	22.35	18.1	23.63	23.31	24.13
PBDTM(%)	-	-	-	-	-
PATM(%)	13.55	10.72	14.06	12.97	14.08

No Record Found

Invest wise with Expert advice